Gloperba®(colchicine) Oral Solution
Annual Sales
Company AVION PHARMACEUTICALS
Date of First Filing April 2, 2020
Paragraph IV Applicant: Granules
Case Name: AVION PHARMACEUTICALS LLC et al v. GRANULES PHARMACEUTICALS INC
Court/Case #: Delaware District Court (dedc) 1:2020cv00898
Date Filed: 7/1/20
Judge:
Product Strength:…[Read more]
The Paragraph Four Report®
Paragraph IV Activity for June 2020
New Certifications as reported by FDA on June 1, 15, and 29, 2020
1. Edarbi®(azilsartan) Tablets 40 mg and 80 mg on 4/10/2020
2. Venclexta®(venetoclax) 10 mg, 50 mg, and 100 mg on 4/13/2020
3. Gocovri®(amantadine) Extended-release Capsules 68.5 mg on 4/30/2020
4. Bri…[Read more]
The Paragraph Four Report®
Paragraph IV Activity for May 2020
New Certifications as reported by FDA on May 19, 2020
1. Gloperba®(colchicine) Oral Solution 0.6mg/5mL on 4/2/2020
Comments: The PIV List has seen colchicine products in the past.
New Cases Filed
1. Product: Bryhali®(halobetasol) Lotion
Case: BAUSCH HEALTH IRELAND LI…[Read more]
.
